Less than a month after DuPont announced plans to invest $200 million into the DuPont Experimental Station to create an incubation center, the Nemours Children’s Health System announced it will move its biomedical research operations there.
Nemours, an internationally renowned children’s health system which operates the Nemours Alfred I. DuPont Hospital for Children in Wilmington, Delaware, will lease two floors of a facility on the DuPont Experimental Station Campus. The space will serve as the new home to research units studying childhood cancer, orthopedics, neuroscience, regenerative medicine, biomedical engineering and applied clinical genomics.
DuPont Experimental Station: A hub for bioscience startups
DuPont will renovate the Experimental Station’s lab space and construct collaboration centers for DuPont customers and suppliers, as well as third-party science companies. The investment and upgrades to the Experimental Station are aimed at creating a high-tech space for research and development. The Station will include an innovation center with a business incubator, accelerator, meeting space and lab facilities.
This state-of-the-art space, along with Delaware’s deep talent pool of scientists and business professionals, makes Delaware uniquely well-suited to support international science and technology companies looking to establish operations in the U.S.
Science companies interested in learning more about how they can join the new collaboration space at DuPont’s Experimental Station, should contact Global Delaware. We would be happy to provide you with additional information and arrange for you to see the facilities.
Never miss an event or update: subscribe to our newsletter